FERMT2 and Alzheimer disease: The integrin‐associated receptor FERMT2 is posited to play a pivotal role in mediating the interactions between brain viscoelasticity, ECM dynamics, and BBB functionality, thereby significantly impacting the progression of AD [25, 26].